Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp at Oppenheimer Healthcare Conference Transcript

Mar 19, 2019 / 12:00PM GMT
Release Date Price: €49.59 (+0.10%)
Steven Michael Lichtman
Oppenheimer & Co. Inc., Research Division - MD and Senior Analyst

Okay. Good morning. Welcome to the 29th Annual Oppenheimer Healthcare Conference. I'm Steve Lichtman, medical device analyst at Oppenheimer.

Very happy to have with us today Integra LifeSciences kicking off the day. With us today is Glenn Coleman, Chief Financial Officer of Integra. Also in the room, Mike Beaulieu from Investor Relations. Glenn's going to have some prepared remarks, and then we'll have some time for Q&A here in the room.

Turn it over to Glenn. Thanks, Glenn.

Glenn G. Coleman
Integra LifeSciences Holdings Corporation - Corporate VP of International & CFO

Thanks, Steve. Good morning to everybody in the room. Good morning to those listening in on the webcast. It's a pleasure to be here at the 29th Annual Oppenheimer Healthcare Conference, so thank you, Steve, for having us.

My name is Glenn Coleman. I'm Chief Financial Officer and Corporate Vice President for International Business at Integra LifeSciences. I'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot